High quality drug screening by capillary electrophoresis: A review |
| |
Authors: | Meera ShanmuganathanAuthor Vitae Philip Britz-McKibbin |
| |
Affiliation: | Department of Chemistry and Chemical Biology, McMaster University, 1280 Main St. West, Hamilton, ON L8S 4M1, Canada |
| |
Abstract: | ![]() High quality assays are needed in drug discovery to reduce the high attrition rate of lead compounds during primary screening. Capillary electrophoresis (CE) represents a versatile micro-separation technique for resolution of enzyme-catalyzed reactions, including substrate(s), product(s), cofactor(s) and their stereoisomers, which is needed for reliable characterization of biomolecular interactions in free solution. This review article provides a critical overview of new advances in CE for drug screening over the past five years involving biologically relevant enzymes of therapeutic interest, including transferases, hydrolases, oxidoreductases, and isomerases. The basic principles and major configurations in CE, as well as data processing methods needed for rigorous characterization of enzyme inhibition are described. New developments in functional screening of small molecules that modulate the activity of disease-related enzymes are also discussed. Although inhibition is a widely measured response in most enzyme assays, other important outcomes of ligand interactions on protein structure/function that impact the therapeutic potential of a drug will also be highlighted, such as enzyme stabilization, activation and/or catalytic uncoupling. CE offers a selective platform for drug screening that reduces false-positives while also enabling the analysis of low amounts of complex sample mixtures with minimal sample handling. |
| |
Keywords: | ACE, angiotensin I-converting enzyme AChE, acetylcholinesterase AD, Alzheimer's disease ADP, adenosine diphosphate AK, adenosine kinase AMP, adenosine monophosphate APES, aminopropyltriethoxysilane APPI, atmospheric pressure photoionization ATP, adenosine triphospate BGE, background electrolyte 3-BrPA, 3-bromo-2-oxopropionic acid BVDU, (E)-5-(2-bromovinyl)-2&prime -deoxyuridine CE, capillary electrophoresis CK2, casein kinase II ΔCM, mid-point for inactivation Com, competitive inhibitor CYP, cytochrome P450 EHNA, erythro-9-(2-hydroxy-3-nonyl) adenine EOF, electroosmotic flow ESI, electrospray ionization ESI-MS, electrospray ionization- mass spectrometry GCase, β-glucocerebrosidase GCV, ganciclovir HDB, hexadimethrine bromide Hip-His-Leu, hippurylhisidylleucine tripeptide HSV-1, herpes simplex virus type 1 HTS, high-throughput screening HyPRE, Hydroxyproline epimerase IC50, half-maximal inhibition constant IMER, immobilized enzyme microreactor 5-IT, 5-iodotubercidin KI, inhibition constant Km, Michaelis&ndash Menten constant IFG, isofagomine LC&ndash MS, liquid chromatography&ndash mass spectrometry LIF, laser-induced ?uorescence MAO-B, Monoamine oxidase B MEKC, micellar electrokinetic chromatography Mix, mixed-type inhibitor MS/MS, tandem mass spectrometry MU, 4-methylumbelliferone MUG, 4-methylumbelliferyl-β-d-gluopyranoside NADPH, nicotinamide adenine dinucleotide phosphate nd, not determined Non, non-competitive inhibitor NPP, ecto-nucleotide pyrophosphatase-phosphodiesterase ONPTG, 2-nitrophenyl-1-thio-β-d-thiogalactopyranoside PA, polyacrylamide PCs, pharmacological chaperones PDDA, Poly(diallyldimethyl ammonium chloride PEA, polyethylenamine PEI, polyethylenimine PNPG, p-nitrophenyl-β/α-d-glucopyranoside PRAC, Proline epimerase PYC, pyrrole 2-carboxylic acid READ, restoration of enzyme activity upon denaturation SDS, sodium dodecyl sulfate SPR, surface plasmon resonance TDLFP, transverse diffusion of laminar flow profiles TK, thymidine kinase TyrK, tyrosine kinase WNK1, with-no-K[Lys] kinase XOD, xanthine oxidase |
本文献已被 ScienceDirect 等数据库收录! |
|